Midatech Pharma plc Operating Income 2011-2025 | MTP

Operating profit (also called operating income or profit from core activities) is a financial metric that reflects a company's profit from its main operational activities before interest expenses and taxes are taken into account.

Formula

Operating profit = Revenue – Operating expenses

Features of the metric

Evaluates business efficiency
Shows how well the company controls its production and administrative costs.
Independent of financial structure
Excludes the impact of debt burden (interest) and taxes, allowing objective comparison of companies.
Main source for growth
High operating profit provides resources for investments, business expansion, and increased competitiveness.

If a company shows strong operating profit, it signals to investors that the core business is operating efficiently, even if net profit is temporarily reduced due to debt or tax burden.

Annual Operating Income Midatech Pharma plc

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-7 M	-23 M	-11.3 M	-11.8 M	-13.3 M	-9.65 M	-12.9 M	-	-	-	-

All numbers in GBP currency

Indicator range from annual reports

Maximum	Minimum	Average
-7 M	-23 M	-12.7 M

Operating Income of other stocks in the Biotechnology industry

Issuer	Operating Income	Price	% 24h	Market Cap	Country
ARCA biopharma ABIO	-88.1 M	-	1052.0 %	$ 415 M	USA
Amphastar Pharmaceuticals AMPH	205 M	$ 25.27	-2.43 %	$ 1.22 B	USA
MorphoSys AG MOR	-508 M	-	2.43 %	$ 254 M	Germany
Alpine Immune Sciences ALPN	-58.1 M	-	-	$ 2.17 B	USA
Arbutus Biopharma Corporation ABUS	-78.1 M	$ 4.75	1.61 %	$ 788 M	Canada
Aclaris Therapeutics ACRS	-142 M	$ 3.26	-3.12 %	$ 252 M	USA
AlloVir ALVR	-65.4 M	-	4.14 %	$ 49.1 M	USA
Acasti Pharma ACST	-16.7 M	-	4.01 %	$ 150 M	Canada
Adaptimmune Therapeutics plc ADAP	-140 M	-	-15.15 %	$ 60.3 M	Britain
Ampio Pharmaceuticals AMPE	-33.3 M	-	-11.43 %	$ 502 K	USA
Aeglea BioTherapeutics AGLE	-209 M	-	-	$ 1.01 B	USA
Kamada Ltd. KMDA	-696 K	$ 7.03	0.14 %	$ 260 M	Israel
Ascendis Pharma A/S ASND	-452 M	$ 220.27	4.81 %	$ 5 B	Danmark
Albireo Pharma ALBO	-123 M	-	-0.23 %	$ 916 M	USA
Ayala Pharmaceuticals AYLA	-37.5 M	-	-	$ 7.46 M	Israel
Enlivex Therapeutics Ltd. ENLV	-15.9 M	$ 0.91	-5.01 %	$ 18.7 M	Israel
Can-Fite BioPharma Ltd. CANF	-8.13 M	$ 0.28	-2.28 %	$ 609 M	Israel
AstraZeneca PLC AZN	1.06 B	$ 89.78	-0.57 %	$ 96.9 B	Britain
Anika Therapeutics ANIK	-87.6 M	$ 9.57	0.84 %	$ 140 M	USA
Brickell Biotech BBI	-6.36 M	-	-5.38 %	$ 6.06 M	USA
BeiGene, Ltd. BGNE	-568 M	-	0.49 %	$ 251 B	Cayman-islands
Bellicum Pharmaceuticals BLCM	-27 M	-	-9.72 %	$ 5.89 M	USA
Berkeley Lights BLI	-98.1 M	-	-7.31 %	$ 87 M	USA
Benitec Biopharma BNTC	-9.83 M	$ 12.05	-7.06 %	$ 496 M	USA
Aytu BioScience AYTU	-7.83 M	$ 2.34	2.59 %	$ 14.7 M	USA
Nymox Pharmaceutical Corporation NYMX	-12.5 M	-	-19.68 %	$ 18.4 M	Canada
Arena Pharmaceuticals ARNA	-624 M	-	-6.81 %	$ 3.04 B	USA
Biophytis SA BPTS	-26.8 M	-	-13.47 %	$ 169 M	France
Baudax Bio BXRX	-56.8 M	-	0.59 %	$ 63 K	USA
Avenue Therapeutics ATXI	-11.3 M	-	-52.27 %	$ 4.45 M	USA
Catalyst Biosciences CBIO	-67.2 M	$ 14.01	-8.49 %	$ 922 M	USA
ChromaDex Corporation CDXC	7.73 M	-	-0.88 %	$ 598 M	USA
Axon Enterprise AXON	58.5 M	$ 566.18	-2.56 %	$ 42.9 B	USA
Cerus Corporation CERS	-14.2 M	$ 2.16	0.47 %	$ 399 M	USA
Checkpoint Therapeutics CKPT	-56.2 M	-	-	$ 169 M	USA
Caladrius Biosciences CLBS	-22.4 M	-	-16.75 %	$ 25.8 M	USA
Clovis Oncology CLVS	-226 M	-	-7.23 %	$ 13 M	USA
Biogen BIIB	7.04 B	$ 174.42	1.11 %	$ 25.4 B	USA
BioVie BIVI	-18.1 M	$ 1.42	-5.96 %	$ 2.1 M	USA
Celldex Therapeutics CLDX	-195 M	$ 27.36	-2.09 %	$ 1.76 M	USA
Cortexyme CRTX	-34.6 M	-	-1.05 %	$ 67.1 M	USA
Cellectar Biosciences CLRB	-39 M	$ 3.63	-3.97 %	$ 44.4 M	USA
Deciphera Pharmaceuticals DCPH	-211 M	-	-	$ 2.18 B	USA
Biohaven Pharmaceutical Holding Company Ltd. BHVN	-704 M	$ 11.54	0.87 %	$ 746 M	USA